查尔斯河实验室,Charles River Laboratories,
美国查尔斯河实验室国际公司(Charles River Laboratories International Inc)
Accelerating Drug Development. Exactly.(加快药品研发进程。精益求精。)Charles River 实验室通过提供基础产品和服务,帮助全球的制药和生物科技企业、政府部门和主要学术机构加快他们的研究和药物研发进程。公司遍布世界各地的 9000 多名员工,致力于为客户提供他们真正需要的产品和服务,以改进和加速患者所需的新疗法的发现、首次临床试验测评的开展以及药品的安全生产。
作为全球最大的实验动物公司,Charles River Laboratories一直是全球实验动物商业化繁育和市场供应的领导者,拥有分布在北美、欧洲和日本的15个分设施和遍布全球的销售网络。从COBS®(Cesarean-Originated-Barrier-Sustained)技术发展到VAF®(Virus Antibody Free)生产过程的引进,Charles River Laboratories不断提高技术并获得了良好的声誉。现在,Charles River Laboratories已经拥有超过130种遗传学背景和微生物学背景清晰定义的实验动物。在坚实卓越的实验动物产业的基础上,Charles River Laboratories不断创新,已成为一个生物医学前临床产品和服务的主要供应商。Charles River Laboratories为客户提供以下高品质产品和优质服务:
研究模型、遗传模型、啮齿类动物外科手术、动物诊断、病理学、毒理学、药效学实验、转基因动物、遗传检测、内毒素监测、生物安全性检测等
For more than 60 years, Charles River has provided tailored research models and laboratory animal support services, as well as preclinical and clinical services, to help our global partners accelerate their research and drug development efforts. Our offerings span the entire drug development process, from discovery through market approval, forming a seamless partnership throughout the process.
From the global standardization of our research models to the high standards we set for our professional team and our state-of-the-art facilities and technologies, we can customize our products and services to meet your specific project needs. With multiple locations around the world, Charles River is the ideal partner for moving your product from animal to man in a rational, cost-effective, and timely manner.
Our partners include all of the major pharmaceutical and biotechnology companies worldwide, as well as government research centers and leading hospital and academic institutions. Our approach – outstanding customer service and commitment to scientific excellence through best-in-class products, services, and procedures – has led to long-standing relationships with many of our customers. Because of this commitment, we continue to count each of our top 20 customers from 1990 as valued partners today.